Quantifying the benefit of the addition of pertuzumab to standard neoadjuvant chemotherapy plus trastuzumab for HER 2 positive breast cancer: The experience of a single oncology unit

被引：0
作者：
Kong, Jun Beng [1 ]
Thomson, Jacqui [1 ]
机构：
[1] Peninsula Hlth, Frankston Hosp, Med Oncol, Frankston, Vic, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
233
引用
收藏
页码：125 / 126
页数：2
相关论文
共 3 条
  • [1] Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes A Meta-Analysis
    Broglio, Kristine R.
    Quintana, Melanie
    Foster, Margaret
    Olinger, Melissa
    McGlothlin, Anna
    Berry, Scott M.
    Boileau, Jean-Francois
    Brezden-Masley, Christine
    Chia, Stephen
    Dent, Susan
    Gelmon, Karen
    Paterson, Alexander
    Rayson, Daniel
    Berry, Donald A.
    [J]. JAMA ONCOLOGY, 2016, 2 (06) : 751 - 760
  • [2] Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
    Gianni, Luca
    Pienkowski, Tadeusz
    Im, Young-Hyuck
    Roman, Laslo
    Tseng, Ling-Ming
    Liu, Mei-Ching
    Lluch, Ana
    Staroslawska, Elzbieta
    de la Haba-Rodriguez, Juan
    Im, Seock-Ah
    Pedrini, Jose Luiz
    Poirier, Brigitte
    Morandi, Paolo
    Semiglazov, Vladimir
    Srimuninnimit, Vichien
    Bianchi, Giulia
    Szado, Tania
    Ratnayake, Jayantha
    Ross, Graham
    Valagussa, Pinuccia
    [J]. LANCET ONCOLOGY, 2012, 13 (01) : 25 - 32
  • [3] Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia The PEONY Phase 3 Randomized Clinical Trial
    Shao, Zhimin
    Pang, Da
    Yang, Hongjian
    Li, Wei
    Wang, Shusen
    Cui, Shude
    Liao, Ning
    Wang, Yongsheng
    Wang, Chuan
    Chang, Yuan-Ching
    Wang, Hweichung
    Kang, Seok Yun
    Seo, Jae Hong
    Shen, Kunwei
    Laohawiriyakamol, Suphawat
    Jiang, Zefei
    Li, Junjie
    Zhou, Julian
    Althaus, Betsy
    Mao, Yixiang
    Eng-Wong, Jennifer
    [J]. JAMA ONCOLOGY, 2020, 6 (03)
1